Those with keen eyes walking through the city centre in recent days may have noticed that some Co-op stores have gone through a clever rebrand.
It may not have caught the eyes straight away, but after a closer look, shoppers will have noticed that branches of the supermarket retailer in major UK cities are now going by the alternative name of Co-op26 – and it’s all part of Co-op’s bid to “engage customers” throughout the COP26 conference and beyond.
The United Nations’ climate change conference COP26 is taking place in Glasgow from Sunday 31 October – Friday 12 November.
The retailer says the Co-op26 campaign is aiming to get people right across the country asking questions about how they can impact climate change at a community level.
Six flagship Co-op stores across the UK – including the branch on High Street in Manchester city centre – have fully been rebranded to Co-op26, with bright blue exterior signage and window vinyl takeovers attempting to capture the attention of passers’ by, while the rest of the retailer’s 2,600 food stores and 830 funeral care homes also have everything from hanging boards, shelf edge labels, and bunting, to exterior bollard covers, and in-store radio takeovers to communicate the message and encourage customers to get involved.
ADVERTISEMENT
Six flagship Co-op stores across the UK have been rebranded – including the branch on High Street in Manchester city centre / Credit: Twitter (@Poody1976) | The Co-op Group
People across the UK having been taking to social media in recent days to share their reactions and thoughts on the rebranding, as well as posting photos of their local Co-op branches looking a little different to usual.
The rebranding appears to have been widely praised by many, with one shopper on Twitter simply telling Co-op “well played”.
ADVERTISEMENT
Jackson Mills – Area Manager at Manchester’s Co-op stores – also shared a video of the High Street store’s rebranding on Twitter, adding in the caption: So proud that Co-op is supporting #COP26. I’m outside High Street Co-op today looking at our new display, asking people to co-operate together and make a difference.
It’s not only the stores that’ll be taking part either.
ADVERTISEMENT
Continuing with the play on words, Co-op has also rebranded all its social media channels to Co-op26 for the duration of the conference too.
“Climate action needs to be truly accessible and inclusive in order to make the difference that’s so urgently needed,” explained Steve Murrells – CEO of The Co-op Group.
“While the world looks to the COP26 conference to guide global leaders on how countries can accelerate change, we are shining a spotlight on how Co-op, our customers, members and colleagues can all play their part in the fight against climate change on a community level.
“Through the launch of the Co-op26 campaign, we want to grab the attention of communities all across the UK to get them thinking, asking questions and taking action, as well as equip them to use their voice and successfully activate the ‘tell your politician’ pledge.”
New endometriosis pill helping hundreds of women with ‘debilitating’ condition to be made available on NHS
Emily Sergeant
A groundbreaking new pill to help women with a ‘debilitating’ condition is set to be made available on the NHS.
The new daily pill for endometriosis – which has been approved for use on the NHS in England by the National Institute for Health and Care Excellence (NICE) – is called linzagolix, and will be available for those who have had previous treatment for endometriosis, working to manage any symptoms they may be experiencing.
Around 1.5 million women in the UK are thought to be currently living with endometriosis.
Endometriosis can cause chronic pain, heavy periods, and extreme tiredness when tissue similar to the womb lining grows elsewhere in the body.
A new daily pill for endometriosis has been approved for use on the NHS, and could help over a thousand women in England every year manage the symptoms of the debilitating condition.
As mentioned, linzagolix will be available specifically for patients whose previous medical or surgical treatments for endometriosis have been unsuccessful, and will be given alongside ‘add-back’ hormone therapy – which involves using low-dose hormone replacement therapy (HRT) to prevent menopause-like symptoms and bone loss.
This is the second take-at-home treatment to be approved to treat endometriosis on the NHS, and it’s thought that more than 1,000 women will benefit.
In clinical trials, linzagolix was shown to be successful in reducing painful periods and non-menstrual pelvic pain, compared with placebo, hence why it has been approved on the NHS by NICE.
“This is welcome news for women with endometriosis who haven’t found relief from previous therapies or surgery,” commented Dr Sue Mann, who is the National Clinical Director in Women’s Health for NHS England.
“It’s another treatment option which will help women take control of their health and better manage the symptoms of this often painful and debilitating condition.
“This is a testament to our ongoing commitment to improving treatment, care and quality of life for women.”
Featured Image – Heute
News
Wigan woman jailed after hitting pedestrian in Fiat 500 while driving high on nitrous oxide ‘balloons’
Emily Sergeant
A young woman from Wigan has been handed jail time after hitting a pedestrian while driving high on nitrous oxide.
Louisa Tunstall was driving a white Fiat 500 towards the East Lancashire Road in Wigan at around 7pm on Friday 24 May 2024 – a time when traffic conditions were said to be ‘quiet’ – but Tunstall was under the influence of a now-banned drug, nitrous oxide, at the time of the incident, Greater Manchester Police (GMP) confirmed.
While driving under the influence, 19-year-old Tunstall veered to the left onto the pavement and collided with a 51-year-old woman pedestrian.
After striking the woman, the car then overturned and, in the process, caused serious life-changing injuries.
When questioned by police, Tunstall stated that she ‘took her eyes off the road’ to retrieve something in the footwell before knowing the car had flipped, but she also confirmed that she had just been out to purchase nitrous oxide to use that evening.
After obtaining witness accounts, investigating officers were able to track down nearby CCTV footable which showed Tunstall inhaling nitrous oxide through a balloon whilst driving, seconds before the collision occurred.
#JAILED | It's not a laughing matter when you get behind the wheel under the influence of drugs.
Now Louisa Tunstall has to spend over a year behind bars after inhaling nitrous oxide and causing serious injury in #Wigan last year.
— Greater Manchester Police (@gmpolice) May 14, 2025
Further investigation by GMP’s Forensic Vehicle Examination Unit examined the Fiat 500 and confirmed that no defects were found on the car to contribute towards the collision.
Still to this day, the victim says she is trying to recover from the injuries sustained to her leg that will prevent her from continuing life as she did before.
“The incident is still very raw when I think about it,” the victim explained in her impact statement released by GMP. “I become upset when I think at everything which has been taken away from me and the ongoing affect it has had and continues to have on my daily life.”
GMP says it’s seeing the use of nitrous oxide being a factor in incidents they attend increasing year on year.
Nitrous oxide, also known as ‘laughing gas’, is reported to produce euphoria, relaxation, dizziness, giggling or laughing fits, impaired judgement, and occasionally dissociation and hallucinations – which GMP says affects reaction time and and is ‘likely lead to impairment’ in driving performance, particularly when faced with an unexpected or hazardous situation.
Tunstall appeared at Bolton Crown Court this week, and has been sentenced to one year and eight months imprisonment for having possession of a Class C drug, driving under the influence of drugs, and causing serious injury by dangerous driving.
Alongside being jailed, she was also disqualified from driving for two years and eight months, and has been ordered to take an extended test when she is released.